Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losanet AM Plus Trial: Fixed vs. Free Triple Combination for Hypertension
NCT03578042Phase 4Unknown
- Sponsor
- Hôtel-Dieu de France
- Start
- Apr 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of losartan, amlodipine and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Hôtel-Dieu de France. Primary endpoint: Average 24 hour blood pressure measured by ambulatory recording at 2 months. Status: unknown.
02
Drugs
losartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03578042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03578042.